Prescription costs

RxSaver and GeniusRx Bring Consumers Low Rx Prices With Free Home Delivery

Retrieved on: 
Tuesday, June 23, 2020
Health, Articles, Pharmaceuticals policy, Clinical pharmacology, Online pharmacy, Pharmaceutical industry, Pharmacy, Medical prescription, Prescription costs, Online shopping, Prescription drug, Independent pharmacy

The new collaboration allows consumers to both save on prescription costs and get convenient, reliable home delivery of medication.

Key Points: 
  • The new collaboration allows consumers to both save on prescription costs and get convenient, reliable home delivery of medication.
  • Consumers can see 1,500+ GeniusRx medications in the RxSaver website and app, making it easy to compare the online pharmacy's pricing-- which includes free home delivery-- with that of retail pharmacies.
  • Consumers who select "Mail My Prescriptions" will receive free home delivery of their medication from GeniusRx's US-based pharmacy.
  • RxSaver's free-to-use prescription coupon platform gathers drug prices from every major pharmacy to help consumers compare medication prices and save.

Kaiser Permanente Joins Forces with Civica Rx to Improve Availability and Affordability of Essential Generic Medications

Retrieved on: 
Thursday, June 18, 2020
Health, Articles, Pharmaceuticals policy, Pharmaceutical industry, Pharmacy, Drugs, Biotechnology, Kaiser Permanente, Civica Rx, Prescription drug, Generic drug, Prescription costs

The addition of Kaiser Permanente comes at a time when Civica is already delivering 20 essential generic medications, 10 of which are currently being used to treat COVID-19 patients.

Key Points: 
  • The addition of Kaiser Permanente comes at a time when Civica is already delivering 20 essential generic medications, 10 of which are currently being used to treat COVID-19 patients.
  • Civica Rx was founded in 2018 by leading U.S. health systems concerned with shortages of essential generic drugs and philanthropic organizations passionate about improving health care.
  • Kaiser Permanente has a deep commitment to lowering prescription drug prices and reducing barriers to generic and biosimilar drug adoption.
  • Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health.

Generic ED Drug Prices Drop, Branded Drug Prices Rise During COVID-19

Retrieved on: 
Tuesday, May 5, 2020
General Health, Health, Professional services, Other Professional Services, Pharmaceutical, Health, Articles, Pharmaceuticals policy, Pharmaceutical industry, Pharmacy, Drugs, RTT, Tadalafil, Prescription drug, Generic drug, Prescription costs, Prescription drug prices in the United States

Generic drug prices continued to fall between January and February 2020, with Tadalafil daily, the generic drug for Cialis Daily, experiencing the sharpest decline at 22.96%.

Key Points: 
  • Generic drug prices continued to fall between January and February 2020, with Tadalafil daily, the generic drug for Cialis Daily, experiencing the sharpest decline at 22.96%.
  • As branded drug prices rise, its important for patients to have access to affordable prescription medications.
  • eDrugstore.com offers cost-effective branded and generic ED medications online.
  • And we will continue monitoring prescription prices to see if they hold insights for drug prices in general during COVID-19.

New Animated Series Aims to Help Patients "Escape the Drug Pricing Maze"

Retrieved on: 
Wednesday, March 25, 2020
Pharmaceutical industry, Medication, Pricing, Prescription costs, Articles, Natural sciences, Chemistry

The new series will educate viewers on how the current drug pricing system is fueled by misguided policies that drive up costs, and how free-market reforms would steer us toward lower prices and more innovation.

Key Points: 
  • The new series will educate viewers on how the current drug pricing system is fueled by misguided policies that drive up costs, and how free-market reforms would steer us toward lower prices and more innovation.
  • "There is a lot of confusion and misinformation surrounding drug price control legislation and proposals to import drugs from foreign countries.
  • In the "Escape the Drug Pricing Maze" series, Professor Salvare guides Pete Paystoomuch through the drug pricing maze, showing in a lighthearted, easy-to-understand way how the direction policymakers take on drug pricing policy could impact the affordability and availability of current medicines, and innovation that could lead to future, life-saving cures.
  • Future videos in the series will address the following topics:
    Why drug prices are higher in the U.S., and when they are cheaper
    "Our new animated series aims to help patients navigate through the 'drug pricing maze,' learn the basics about how drugs are priced, and why reforms to fix this complicated system are needed to increase affordability and ensure future innovation," concluded Winegarden.

2020 Drug Patent Database Subscription: U.S. Drug Prices - ResearchAndMarkets.com

Retrieved on: 
Friday, March 20, 2020
Health, Pharmaceutical, Pharmaceutical industry, Health, Articles, Pharmacy, Media industry, Subscription business model, Prescription costs, Medication, Drug, Subscription, Patent

The "Drug Patent Database Subscription: US Drug Prices" newsletter has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Patent Database Subscription: US Drug Prices" newsletter has been added to ResearchAndMarkets.com's offering.
  • This subscription was created to answer a simple question: When do drug patents expire?
  • Since then dozens of additional datasets have been added by aggressive adaptation based on your needs.
  • This subscription for the US Drug Prices portion of the database offers information on:
    Global biopharmaceutical markets face constant change.

A US-Based Generic Drugs Market Client Achieved Savings of Over $8.8 Million with Market Intelligence Engagement | RFP for Similar Engagement for Your Business

Retrieved on: 
Tuesday, March 17, 2020
General Health, Pharmaceutical, Health, Health, Articles, Pharmacy, Pharmaceuticals policy, Generic drug, Public domain, Pharmaceutical industry, Prescription costs

Also, gather detailed insights into the approach undertaken by the experts at Infiniti Research to help the generic drugs market client achieve savings of over $8.8 million in a year.

Key Points: 
  • Also, gather detailed insights into the approach undertaken by the experts at Infiniti Research to help the generic drugs market client achieve savings of over $8.8 million in a year.
  • However, evolving governmental regulations and rising generic drug prices are expected to hamper the generic drugs market development.
  • As such, generic drugs manufacturers will need to foresee changing market dynamics and look for other markets to sustain growth.
  • Besides, the rising concerns about the safety and efficacy of extended-release generic drugs made it difficult for the generic drugs market client to promote their products.

FDA Approves First Generic of Daraprim

Retrieved on: 
Friday, February 28, 2020
Health, Articles, Pharmacy, Pharmaceuticals policy, Food and Drug Administration, United States Public Health Service, Generic drug, Pyrimethamine, Pharmaceutical industry, Prescription costs, Prescription drug prices in the United States, Abbreviated New Drug Application

"The FDA has a longstanding commitment to increasing competition in markets with limited or no generic alternatives.

Key Points: 
  • "The FDA has a longstanding commitment to increasing competition in markets with limited or no generic alternatives.
  • FDA analysis has shown that greater competition among generic drug makers is associated with lower generic drug prices.
  • To improve transparency about this issue, the FDA posted a list identifying all drugs for which the FDA has received an inquiry related to limited distribution of the reference drug from a prospective generic applicant.
  • The sponsor of the approved generic version of Daraprim Tablets is Cerovene Inc.

University of California, Berkeley, Study Confirms Efficacy of Prescription Drug Reference Pricing for Lowering Drug Costs for Employers and Patients

Retrieved on: 
Tuesday, February 11, 2020
General Health, Health, Professional services, Pharmaceutical, Insurance, Health, Articles, Pharmaceuticals policy, Pharmacy, Pharmaceutical industry, Clinical pharmacology, Drugs, Prescription drug, Prescription costs, Pricing, Prescription drug prices in the United States

ActiveRADAR , a company specializing in prescription drug cost reduction programs for employers, trust funds and health plans, announced the release of a new study led by researchers at University of California, Berkeley, that demonstrates the efficacy of prescription drug reference pricing to lower annual drug costs for employers and patients.

Key Points: 
  • ActiveRADAR , a company specializing in prescription drug cost reduction programs for employers, trust funds and health plans, announced the release of a new study led by researchers at University of California, Berkeley, that demonstrates the efficacy of prescription drug reference pricing to lower annual drug costs for employers and patients.
  • The study, which leveraged ActiveRADARs solution, found that reference pricing encourages patients to switch to lower-priced drugs, delivering significant cost-savings that increase over time.
  • By leveraging advanced algorithms, clinical research and the principles of behavioral economics, this approach drives down drug prices immediately, efficiently and extremely.
  • The research team found that implementing reference pricing measurably lowered prescription drug spending for the employer (plan sponsor) as well as reduced costs for employees over time.

SingleCare Partners With WebMD to Launch WebMDRx, Offering Consumers up to 80% Savings on Prescription Drugs

Retrieved on: 
Tuesday, January 14, 2020
Technology, MEN, Retail, Health, Family, Consumer, Pharmaceutical, Other Retail, Software, General Health, Internet, Specialty, Women, Data management, Health, Pharmaceuticals policy, Clinical pharmacology, Drugs, Health websites, Prescription drug, WebMD, Pharmacy, Prescription costs, Medical prescription, Online pharmacy, SingleCare, RxSense, WebMD, Internet Brands

Consumers visiting WebMD can now easily compare prescription drug prices at local pharmacies and save money with WebMDRx discounts.

Key Points: 
  • Consumers visiting WebMD can now easily compare prescription drug prices at local pharmacies and save money with WebMDRx discounts.
  • Our partnership with WebMD to power its prescription savings program extends the SingleCare mission to make prescription drugs more affordable to the millions of consumers who use WebMD each month," said Rick Bates, CEO and co-founder of RxSense , SingleCare's parent company.
  • Partnering with SingleCare enables us to build on our commitment by strengthening WebMDRx with expanded locations and greater consumer savings.
  • Through this partnership, SingleCare is expanding its reach to make prescription drug savings available to the millions of people who visit WebMD.

AARP Ohio Applauds the House for Passing the Elijah E. Cummings Lower Drug Costs Now Act

Retrieved on: 
Friday, December 13, 2019
Health, Articles, Pharmacy, Pharmaceuticals policy, AARP, Pharmaceutical industry, Drugs, Elijah Cummings, Prescription costs, Prescription drug, Out-of-pocket expense

3, the Elijah E. Cummings Lower Drug Costs Now Act.

Key Points: 
  • 3, the Elijah E. Cummings Lower Drug Costs Now Act.
  • "AARP Ohio commends Reps. Beatty, Fudge, Kaptur and Ryan for helping pass the Elijah E. Cummings Lower Drug Costs Now Act in the U.S. House of Representatives.
  • This bipartisan legislation is a bold step toward lowering prescription drug prices and high out-of-pocket costs for millions of older Americans, including our 1.5 million Ohio members.
  • AARP also produces the nation's largest circulation publications: AARP The Magazine and AARP Bulletin.